XBIT - XBiotech Inc.
2.33
-0.020 -0.858%
Share volume: 13,920
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.35
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-13-2024 | 03-18-2025 | 05-14-2025 | 08-13-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 10.853 M | 14.966 M | 7.904 M | 8.748 M | 13.550 M | 6.336 M | 6.047 M | |
| Selling general and admin | 1.028 M | 1.982 M | 777.000 K | 927.000 K | 1.931 M | 1.000 M | 967.000 K | |
| Research and development | 9.825 M | 12.984 M | 7.127 M | 7.821 M | 11.619 M | 5.336 M | 5.080 M | |
| Total expenses | 10.853 M | 14.966 M | 7.904 M | 8.748 M | 13.550 M | 6.336 M | 6.047 M | |
| 37.90% | -47.19% | 10.68% | 54.89% | -53.24% | -4.56% | |||
| Operating income | -10.853 M | -14.966 M | -7.904 M | -8.748 M | -13.550 M | -6.336 M | -6.047 M | |
| Ebit | -12.635 M | -15.720 M | -7.172 M | -12.041 M | -12.271 M | -3.258 M | -7.333 M | |
| Pretax income | -9.977 M | -13.031 M | -5.006 M | -10.549 M | -10.855 M | -1.728 M | -5.906 M | |
| 30.61% | -61.58% | 110.73% | 2.90% | -84.08% | 241.78% | |||
| Income tax | 25.000 K | -25.000 K | 9.000 K | -41.000 K | 29.000 K | 28.000 K | 102.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.002 M | -13.006 M | -5.015 M | -10.508 M | -10.884 M | -1.756 M | -6.008 M | |
| -30.03% | 61.44% | -109.53% | -3.58% | 83.87% | -242.14% |